Related Experiment Videos
Management of Lyme disease
S D Goodwin1, T T Sproat, W L Russell
1College of Pharmacy, University of Florida, Gainesville.
Clinical Pharmacy
|March 1, 1990
Summary
Lyme disease, a tick-borne illness caused by Borrelia burgdorferi, is reviewed for its microbiology, transmission, and treatment. Early treatment with antibiotics like tetracycline or doxycycline is key to preventing late-stage Lyme disease.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Epidemiology
Background:
- Lyme disease is a prevalent tick-borne illness first identified in 1975.
- Caused by the spirochete Borrelia burgdorferi, it affects multiple body systems.
- Endemic areas in the U.S. include the Northeast, North Central, and Western regions.
Purpose of the Study:
- To provide a comprehensive review of Lyme disease.
- To cover its microbiology, transmission, epidemiology, pathogenesis, clinical features, diagnosis, and treatment.
- To highlight current understanding and treatment strategies.
Main Methods:
- Review of existing literature on Lyme disease.
- Synthesis of information on Borrelia burgdorferi and its effects.
- Analysis of disease stages and therapeutic interventions.
Main Results:
- Lyme disease progresses through three distinct stages: early localized (Stage I), early disseminated (Stage II), and late persistent (Stage III).
- Infectious mechanisms are considered primary in pathogenesis, alongside immunologic factors.
- Antibiotic therapy, including penicillin, tetracycline, and doxycycline, is effective, with tetracycline/doxycycline showing promise in preventing late-stage disease.
Conclusions:
- Early antibiotic treatment hastens symptom resolution and may prevent progression.
- Ceftriaxone is often preferred for late-stage Lyme disease over intravenous penicillin G.
- Optimal treatment strategies, especially for Lyme arthritis, require further clinical investigation.